See the published version of this article at BMC Surgery.
This is a preprint. Preprints are preliminary reports that have not undergone peer review. They should not be considered conclusive, used to inform clinical practice, or referenced by the media as validated information.
Learn more about In Review
Research article
The Impact of COVID-19 on Gastric Cancer Surgery: A Single-Center Retrospective Study
Xiaohui Du
Chinese PLA General Hospital
Corresponding Author
ORCiD: https://orcid.org/0000-0002-8713-1358
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Declarations:
View the published version at BMC Surgery.
Background: The coronavirus disease 2019 (COVID-19) has been declared a global pandemic by the World Health Organization. Patients with cancer are more likely to incur poor clinical outcomes. Due to the prevailing pandemic, we propose some surgical strategies for gastric cancer patients.
Methods: The ‘COVID-19’ period was defined as occurring between 2020-01-20 and 2020-03-20. The enrolled patients were divided into two groups, pre-COVID-19 group (PCG) and COVID-19 group (CG). A total of 109 patients with gastric cancer were enrolled in this study.
Results: The waiting time before admission increased by 4 days in the CG (PCG: 4.5 [IQR: 2, 7.8] vs. CG: 8.0 [IQR: 2,20]; p=0.006). More patients had performed chest CT scans besides abdominal CT before admission during the COVID-19 period (PCG: 22 [32%] vs. CG: 30 [73%], p=0.001). After admission during the COVID period, the waiting time before surgery was longer (PCG: 3[IQR: 2,5] vs. CG: 7[IQR: 5,9]; p<0.001), more laparoscopic surgeries were performed (PCG: 51[75%] vs. CG: 38[92%], p=0.021), and hospital stay period after surgery was longer (7[IQR: 6,8] vs.9[IQR:7,11]; p<0.001). In addition, the total cost of hospitalization increased during this period, (PCG: 9.22[IQR:7.82,10.97] vs. CG: 10.42[IQR:8.99,12.57]; p=0.006).
Conclusion: This study provides an opportunity for our surgical colleagues to reflect on their own services and any contingency plans they may have to tackle the COVID-19 crisis.
Keywords
gastric cancer, coronavirus disease 2019, COVID-19, retrospective analysis
Figure 1
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
Version 3
Posted 23 Sep, 2020
No comments provided
Review #1 received
Received 14 Sep, 2020
Editor assigned
On 11 Sep, 2020
Reviewers invited
Invitations sent on 11 Sep, 2020
Reviewer #1 agreed
On 11 Sep, 2020
Reviewer #2 agreed
On 11 Sep, 2020
Submission checks complete
On 10 Sep, 2020
Editor invited
On 10 Sep, 2020
No comments provided
Review #3 received
Received 07 Aug, 2020
Editorial decision: Minor revision
On 07 Aug, 2020
Reviewer #3 agreed
On 29 Jul, 2020
Reviewer #2 agreed
On 28 Jul, 2020
Review #2 received
Received 28 Jul, 2020
Review #1 received
Received 26 Jul, 2020
Reviewer #1 agreed
On 10 Jul, 2020
Editor assigned
On 09 Jul, 2020
Reviewers invited
Invitations sent on 09 Jul, 2020
Submission checks complete
On 03 Jul, 2020
Editor invited
On 02 Jul, 2020
First submitted
On 12 Jun, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Gastrointestinal Surgery
Learn more about our company.
This preprint is under consideration at BMC Surgery. Preprints are preliminary reports that have not undergone peer review. They should not be considered conclusive, used to inform clinical practice, or referenced by the media as validated information.
Learn more about In Review
Research article
The Impact of COVID-19 on Gastric Cancer Surgery: A Single-Center Retrospective Study
Xiaohui Du
Chinese PLA General Hospital
Corresponding Author
ORCiD: https://orcid.org/0000-0002-8713-1358
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
Version 3
Posted 23 Sep, 2020
No comments provided
Review #1 received
Received 14 Sep, 2020
Editor assigned
On 11 Sep, 2020
Reviewers invited
Invitations sent on 11 Sep, 2020
Reviewer #1 agreed
On 11 Sep, 2020
Reviewer #2 agreed
On 11 Sep, 2020
Submission checks complete
On 10 Sep, 2020
Editor invited
On 10 Sep, 2020
No comments provided
Review #3 received
Received 07 Aug, 2020
Editorial decision: Minor revision
On 07 Aug, 2020
Reviewer #3 agreed
On 29 Jul, 2020
Reviewer #2 agreed
On 28 Jul, 2020
Review #2 received
Received 28 Jul, 2020
Review #1 received
Received 26 Jul, 2020
Reviewer #1 agreed
On 10 Jul, 2020
Editor assigned
On 09 Jul, 2020
Reviewers invited
Invitations sent on 09 Jul, 2020
Submission checks complete
On 03 Jul, 2020
Editor invited
On 02 Jul, 2020
First submitted
On 12 Jun, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Gastrointestinal Surgery
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Declarations:
View the published version at BMC Surgery.
Background: The coronavirus disease 2019 (COVID-19) has been declared a global pandemic by the World Health Organization. Patients with cancer are more likely to incur poor clinical outcomes. Due to the prevailing pandemic, we propose some surgical strategies for gastric cancer patients.
Methods: The ‘COVID-19’ period was defined as occurring between 2020-01-20 and 2020-03-20. The enrolled patients were divided into two groups, pre-COVID-19 group (PCG) and COVID-19 group (CG). A total of 109 patients with gastric cancer were enrolled in this study.
Results: The waiting time before admission increased by 4 days in the CG (PCG: 4.5 [IQR: 2, 7.8] vs. CG: 8.0 [IQR: 2,20]; p=0.006). More patients had performed chest CT scans besides abdominal CT before admission during the COVID-19 period (PCG: 22 [32%] vs. CG: 30 [73%], p=0.001). After admission during the COVID period, the waiting time before surgery was longer (PCG: 3[IQR: 2,5] vs. CG: 7[IQR: 5,9]; p<0.001), more laparoscopic surgeries were performed (PCG: 51[75%] vs. CG: 38[92%], p=0.021), and hospital stay period after surgery was longer (7[IQR: 6,8] vs.9[IQR:7,11]; p<0.001). In addition, the total cost of hospitalization increased during this period, (PCG: 9.22[IQR:7.82,10.97] vs. CG: 10.42[IQR:8.99,12.57]; p=0.006).
Conclusion: This study provides an opportunity for our surgical colleagues to reflect on their own services and any contingency plans they may have to tackle the COVID-19 crisis.
Figure 1